A

Annovis Bio

D
ANVS
USD
-0.44
(-5.9701%)
Market Closed
7,565.00
حجم التداول
-1.7
الربح لكل سهم
-
العائد الربحي
-1.526432
P/E
90,464,344.74
حجم السوق
اليوم
-5.9701%
1 اسبوع
-19.884%
1 شهر
-7.477%
6 اشهر
-16.906%
12 اشهر
17.061%
بداية السنة
-63.040%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Annovis Bio

Sector:
Healthcare
Industry:
Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
هل تحتاج مساعدة او لديك استفسار؟